Skip to main content
. Author manuscript; available in PMC: 2009 Sep 11.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2008;48:463–493. doi: 10.1146/annurev.pharmtox.48.113006.094615

Table 1.

Proposed classification scheme for acute kidney injury (AKI) in patients*

Stage Creatinine criteria Urine output criteria
1 (Risk) Increased SCr of ≥0.3 mg dl−1 or increase to ≥150%−200% from baseline UO <0.5 ml kg−1 h−1 for >6 h
2 (Injury) Increased SCr to >200%−300% UO <0.5 ml kg−1 h−1 for >12 h
3 (Failure) Increase SCr to >300% from baseline (or Scr ≥4 mg dl−1) (acute rise ≥0.5 mg/dl) UO <0.3 ml kg−1 h−1 × 24 h or Anuria × 12 h
Stages eliminated from the original RIFLE criterion
Loss Persistent ARF = complete loss of kidney function >4 weeks
ESKD End-stage kidney disease (>3 months)

ARF: Acute renal failure; ESKD: end-stage kidney disease; RIFLE: Risk of renal dysfunction; injury to the kidney; failure of kidney function; loss of kidney function; end-stage kidney disease; SCr: serum creatinine; UO: urine output.

*

Adapted from Reference 23.